Last updated on May 2018

A Study to Investigate the Safety Tolerability and Pharmacokinetics of Single and Repeat Doses of PC945


Brief description of study

PC945 is a new medicine being developed for treatment of fungal lung diseases. The main purpose of this study is to investigate the safety, tolerability and pharmacokinetics of single and repeat doses of PC945

Clinical Study Identifier: NCT02715570

Contact Investigators or Research Sites near you

Start Over

Volunteer Recruitment

Parexel EPCU
Harrow, United Kingdom